Young Joseph R
SEC insider (Form 3/4/5 filer). CIK 0001861684. SVP, FINANCE, CHIEF ACCT OFFCR at Vera Therapeutics, Inc. (VERA). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in BRISBANE, CA.
Companies Young Joseph R has filed insider reports for
- Vera Therapeutics, Inc. (VERA): Officer, SVP, FINANCE, CHIEF ACCT OFFCR
Young Joseph R
CIK: 0001861684
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vera Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 11, 2026VERA
Vera Therapeutics, Inc.
ExerciseDirect5K shares at avg. $3.94$20K - Mar 13, 2026VERA
Vera Therapeutics, Inc.
ExerciseDirect10K shares at avg. $3.94$39K - Feb 23, 2026VERA
Vera Therapeutics, Inc.
SaleDirect3.1K shares at avg. $41.98$131K - Feb 4, 2026VERA
Vera Therapeutics, Inc.
AwardDirect10K shares- - Nov 13, 2025VERA
Vera Therapeutics, Inc.
ExerciseDirect10K shares at avg. $3.94$39K - Nov 11, 2025VERA
Vera Therapeutics, Inc.
SaleDirect15K shares at avg. $29.06$436K - Feb 18, 2025VERA
Vera Therapeutics, Inc.
AwardDirect10.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 | VERA Vera Therapeutics, Inc. | Exercise | 5,000 | $3.94 | $19,698 | Direct |
| Mar 13, 2026 | VERA Vera Therapeutics, Inc. | Exercise | 10,000 | $3.94 | $39,396 | Direct |
| Feb 23, 2026 | VERA Vera Therapeutics, Inc. | Sale | 3,117 | $41.98 | $130,864 | Direct |
| Feb 4, 2026 | VERA Vera Therapeutics, Inc. | Award | 10,000 | - | $0 | Direct |
| Nov 13, 2025 | VERA Vera Therapeutics, Inc. | Exercise | 10,000 | $3.94 | $39,396 | Direct |
| Nov 11, 2025 | VERA Vera Therapeutics, Inc. | Sale | 15,000 | $29.06 | $435,875 | Direct |
| Feb 18, 2025 | VERA Vera Therapeutics, Inc. | Award | 10,740 | - | - | Direct |
1-7 of 7 transactions